VAXCYTE INC (PCVX) Stock News
NASDAQ:PCVX - Nasdaq - US92243G1085 - Common Stock - Currency: USD
PCVX Latest News, Press Relases and Analysis
Top stock movements in today's session.
Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Monday's session: top gainers and losers
Here are the top movers in Monday's session, showcasing the stocks with significant price changes.
Vaxcyte, Inc. (PCVX): Billionaire Stanley Druckenmiller’s Top Stock Pick with Huge Upside Potential
We recently published a list of Billionaire Stanley Druckenmiller’s Top 10 Stocks Picks with Huge Upside Potential. In this article, we are going to take a look at where Vaxcyte, Inc. (NASDAQ:PCVX) stands against Billionaire Stanley Druckenmiller’s other top stock picks with huge upside potential. Wall Street is overflowing with data. If companies are not […]
Lamb Weston Holdings (LW): Among the Best Packaged Food Stocks to Buy Now
We recently published a list of 10 Best Packaged Food Stocks to Buy Now. In this article, we are going to take a look at where Lamb Weston Holdings, Inc. (NYSE:LW) stands against other best packaged food stocks to buy now. The American Packaged Food Industry According to a report by Grand View Research, the […]
Why BellRing Brands (BRBR) Is Among the Best Packaged Food Stocks to Buy Now
We recently published a list of 10 Best Packaged Food Stocks to Buy Now. In this article, we are going to take a look at where BellRing Brands, Inc. (NYSE:BRBR) stands against other best packaged food stocks to buy now. The American Packaged Food Industry According to a report by Grand View Research, the US […]
Is Bristol-Myers Squibb Company (BMY) One of the Best Medical Stocks to Buy According to Billionaires?
We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best medical stocks to buy according to billionaires. Why are Healthcare Stocks Under Pressure? Some experts view medical, healthcare, and big […]
Vaxcyte ‘narrow’ misses in Phase 2 likely to be ok in Phase 3, says Evercore ISI
Evercore ISI notes that Vaxcyte (PCVX) missed four serotypes versus Prevnar20 in the “all-important” infant data, adding that an “imperfect vaccine press release on the heels of Peter Marks resignation is just tough timing.” However, the analyst contends that three of the four misses in today’s Phase 2 are “narrow – and will quite likely be ok” in a larger Phase 3 trial. The firm maintains an Outperform rating on Vaxcyte shares, which are down $34.89, or 50%, to $34.57 in early afternoon trading
Rocket acquires Mr. Cooper, Musk’s xAI acquires X: Morning Buzz
The major averages were mostly lower near noon, with the Dow up fractionally but the Nasdaq down nearly 250 points amid mounting concerns about President Donald Trump’s upcoming announcement of promised new tariffs. Meanwhile, the S&P 500’s early losses brought the index to its lowest level since September. Looking to commodities, gold prices are sharply higher, continuing their rally to over $3,150, while oil prices are also up over 2.5%. Get caught up quickly on the top news and calls moving s
Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr.
The decline in biotech stocks comes after FDA official Peter Marks' resignation, citing irreconcilable differences with the new HHS Secretary.
Coinbase Shares Head for Worst Quarter Since FTX Collapse as Crypto Slumps
(Bloomberg) -- Shares of Coinbase Global Inc. and other firms linked to cryptocurrencies were hammered this quarter as growing concerns about the US economy weighed on digital assets. Most Read from BloombergGold-Rush Fever Returns to Historic New Zealand Mining TownWhat Frank Lloyd Wright Learned From the DesertBank Regulators Fight for Desks as OCC Returns to New York TowerCoinbase fell 31% in the worst quarterly performance since FTX collapsed near the end of 2022. Nearly every major crypto-l
These stocks are gapping in today's session
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.
Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns
Peter Marks heads up the department in charge of reviewing vaccines, genetic medicines and cell therapies.
Monday's pre-market session: top gainers and losers
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study
Vaxcyte, Inc. (PCVX): One of the Best Debt Free Mid Cap Stocks to Buy Now
We recently compiled a list of the 10 Best Debt Free Mid Cap Stocks to Buy Now. In this article, we are going to take a look at where Vaxcyte, Inc. (NASDAQ:PCVX) stands against the other debt free mid cap stocks. Debt-free mid-cap stocks currently offer compelling investment opportunities, especially in today’s high-interest-rate environment. With […]
Mentions: JPM
Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study
Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study
SAN CARLOS, Calif., March 30, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering...
Why Vaxcyte, Inc. (PCVX) Is Among the Best Mid Cap Biotech Stocks to Buy
We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Vaxcyte, Inc. (NASDAQ:PCVX) stands against the other best mid cap biotech stocks to buy. Is the Biotech Sector Oversaturated? On March 6, Jared Holz, Mizuho health care equity […]
Merck Gets EC Nod for 21-Valent Pneumococcal Jab Capvaxive
The European Commission approves MRK's pneumococcal 21-valent conjugate vaccine, Capvaxive, for pneumococcal vaccination in adults.
Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-- Completed Successful VAX-31 Phase 2 Adult Program; Company Remains on Track to Initiate VAX-31 Adult Phase 3 Pivotal, Non-Inferiority Study by Mid-2025...
Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
SAN CARLOS, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity...
RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.
The Senate will vote Thursday on whether to put RFK Jr. in charge of health. It's unclear how he will impact biotech stocks.
Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants
-- Advancement to Stage 2 of Infant Study Supported by Review of Stage 1 Safety and Tolerability Data -- -- Company Expects to Announce VAX-31 Infant...